(Q31043227)

English

High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment (English)

1 reference

Europe PubMed Central

17 September 2017

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

9

object named as

Andrew Z Fire

1 reference

Europe PubMed Central

17 September 2017

author name string

Aaron C Logan

1

1 reference

Europe PubMed Central

17 September 2017

Hong Gao

2

1 reference

Europe PubMed Central

17 September 2017

Chunlin Wang

3

1 reference

Europe PubMed Central

17 September 2017

Bita Sahaf

4

1 reference

Europe PubMed Central

17 September 2017

Carol D Jones

5

1 reference

Europe PubMed Central

17 September 2017

Eleanor L Marshall

6

1 reference

Europe PubMed Central

17 September 2017

Ismael Buño

7

1 reference

Europe PubMed Central

17 September 2017

Randall Armstrong

8

1 reference

Europe PubMed Central

17 September 2017

Kenneth I Weinberg

10

1 reference

Europe PubMed Central

17 September 2017

Michael Mindrinos

11

1 reference

Europe PubMed Central

17 September 2017

James L Zehnder

12

1 reference

Europe PubMed Central

17 September 2017

Scott D Boyd

13

1 reference

Europe PubMed Central

17 September 2017

Wenzhong Xiao

14

1 reference

Europe PubMed Central

17 September 2017

Ronald W Davis

15

1 reference

Europe PubMed Central

17 September 2017

David B Miklos

16

1 reference

Europe PubMed Central

17 September 2017

language of work or name

0 references

publication date

12 December 2011

1 reference

Europe PubMed Central

17 September 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

17 September 2017

108

1 reference

Europe PubMed Central

17 September 2017

21194-21199

1 reference

Europe PubMed Central

17 September 2017

52

1 reference

Europe PubMed Central

17 September 2017

Identification of errors introduced during high throughput sequencing of the T cell receptor repertoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Allogeneic stem cell transplantation for chronic lymphocytic leukemia: lessons to be learned from minimal residual disease studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Is MRD eradication a desirable goal in CLL?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Eradicating minimal residual disease in chronic lymphocytic leukemia: should this be the goal of treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

How I treat CLL up front

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

28 July 2018

State-of-the-art treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Detection of minimal residual disease in B Chronic Lymphocytic Leukemia (CLL)

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1118357109

21 January 2018

Genome sequencing in microfabricated high-density picolitre reactors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248502

25 November 2018

The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective conditioning for acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PCR-based immunogenotyping at the Ig heavy chain CDR3 locus: improvements in resolution

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangements

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.1118357109

1 reference

Europe PubMed Central

17 September 2017

2011PNAS..10821194L

0 references

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31043227&oldid=2010835814"